Determination of the management of a patient with stable ischemic heart disease according to the data of fractional flow reserve study

M.V. Stan, A.V. Khokhlov, О.J. Zharinov, O.V. Zelenchuk, B.M. Todurov

References

1. Boden W.E., Stone P.H. Treating angina after ISCHEMIA – Why a conservative approach with optimalmedical therapy is the preferred initial management strategy for chronic coronary syndromes // Eur. Heart J.– 2021.– Vol. 42 (14).– P. 1394–1400. doi: 10.1093/eurheartj/ehab069.002.
2. Kang S.J., Lee J.Y., Ann J.M. et al. Intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease // JACC Cardiovasc Interv.– 2011.– Vol. 4 (11).– P. 1168–1174. doi: 10.1016/j.jcin.2011.08.009.
3. Kang S.J., Ahn J.M., Shim E.B. et al. Visual-functional mismatch between coronary angiography and fractional flow reserve // JACC Cardiovasc. Interv.– 2012.– Vol. 5 (10).– P. 1029–1036. doi: 10.1016/j.jcin.2012.07.007.
4. Knuuti J., Wijns W., Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes // Eur. Heart J.– 2020.– Vol. 41.– P. 407–477. doi: 10.1093/eurheartj/ehz425.
5. Neumann F.J., Sousa-Uva M., Ahlsson A. et al. 2018 ESC/EACTS guidelines on myocardial revascularization // Eur. Heart J.– 2019.– Vol. 40.– P. 87–165. doi: 10.1093/eurheartj/ehy394.
6. Park S.H., Jeon K.H., Lee J.M. et al. Long-Term Clinical Outcomes of Fractional Flow Reserve-Guided Versus Routine Drug-Eluting Stent Implantation in Patients With Intermediate Coronary Stenosis: Five-Year Clinical Outcomes of DEFER-DES Trial // Circ. Cardiovasc. Interv.– 2015.– Vol. 8–12.
7. Toth G, Hamilos M, Pyxaras S, Mangiacapra F, Nelis O, De Vroey F, et al. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses // Eur. Heart J.– 2014.– Vol. 35 (40).– P. 2831–2838. doi: 10.1093/eurheartj/ehu094